Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
LONG-TERM SURVIVAL IN ADVANCED OVARIAN-CANCER AFTER CYTOREDUCTION AND CHEMOTHERAPY TREATMENT
Gynecologic Oncology (p. 27-32) - 1/1/1994
10.1006/gyno.1994.1082 Ver en origen
- ISSN 00908258
ERBB-2 ANTISENSE OLIGONUCLEOTIDES INHIBIT THE PROLIFERATION OF BREAST-CARCINOMA CELLS WITH ERBB-2 ONCOGENE AMPLIFICATION
- COLOMER, R
- LUPU, R
- BACUS, SS
- GELMANN, EP;
British Journal Of Cancer (p. 819-825) - 1/1/1994
10.1038/bjc.1994.405 Ver en origen
- ISSN 00070920
OVEREXPRESSION OF C-ERBB-2 IN EPITHELIAL OVARIAN-CANCER - PROGNOSTIC VALUE AND RELATIONSHIP WITH RESPONSE TO CHEMOTHERAPY
- Enriqueta Felip
- Josep Maria Del Campo
- Diego Rubio
- Maria Teresa Vidal
- Ramón Colomer
- Begoña Bermejo
Cancer (p. 2147-2152) - 1/1/1995
10.1002/1097-0142(19950415)75:8<2147::aid-cncr2820750818>3.0.co;2-8 Ver en origen
- ISSN 0008543X
- iMarina
- iMarina
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
- Hitt, R
- Hornedo, J
- Colomer, R
- Mendiola, C
- Brandariz, A
- Sevilla, E
- AlvarezVicent, J
- CortesFunes, H;
Seminars In Oncology (p. 50-54) - 1/12/1995
- ISSN 00937754
- iMarina
Genes and breast cancer: Current and future applications
- Colomer R
Revisiones En Cancer (p. 144-152) - 1/12/1995
- ISSN 02138573
- iMarina
IMPROVING TREATMENT OF CHEMOTHERAPY-INDUCED NEUTROPENIC FEVER BY ADMINISTRATION OF COLONY-STIMULATING FACTORS
- JI Mayordomo
- F Rivera
- MT Diaz-Puente
- P Lianes
- R Colomer
- E Lopez-brea
- L Paz-Ares
- R Hitt
- I García-Ribas
- R Cubedo
- S Alonso
- H Cortés-Funes
Jnci-Journal Of The National Cancer Institute (p. 803-808) - 7/6/1995
10.1093/jnci/87.11.803 Ver en origen
- ISSN 00278874
- iMarina
- iMarina
Recall reaction of a severe local peripheral neuropathy after paclitaxel extravasation
- MANUEL HIDALGO
- JULIAN BENITO
- RAMON COLOMER
- LUIS PAZ-ARES
Jnci-Journal Of The National Cancer Institute (p. 1320-1320) - 1/1/1996
10.1093/jnci/88.18.1320-a Ver en origen
- ISSN 00278874
- iMarina
- iMarina
Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines
- Saceda, M
- Grunt, TW
- Colomer, R
- Lippman, ME
- Lupu, R
- Martin, MB;
Endocrinology (p. 4322-4330) - 1/1/1996
10.1210/en.137.10.4322 Ver en origen
- ISSN 00137227
Low levels of basic fibroblast growth factor (bFGF) are associated with a Poor Prognosis in human breast carcinoma
- Colomer, R
- Aparicio, J
- Montero, S
- Guzman, C
- Larrodera, L
- CortesFunes, H;
British Journal Of Cancer (p. 1215-1220) - 1/1/1997
10.1038/bjc.1997.536 Ver en origen
- ISSN 00070920
Should prophylactic surgery be used in women with high risk of breast cancer? Arbiter
- Cortes-Funes, H
- Colomer, R;
European Journal Of Cancer (p. 2158-2159) - 1/1/1997
10.1016/s0959-8049(97)00362-6 Ver en origen
- ISSN 09598049
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratamiento hormonal del cáncer
- Ramón Colomer Bosch
- M L Amador
- J González Cortijo
- MV Tornamira
Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
CA 15.3 - A NEW MARKER FOR BREAST-CANCER (BC) PRELIMINARY-RESULTS
- SOLE, LA
- COLOMER, R
- NAVARRO, M
- ENCABO, G
- RUIBAL, A;
Anticancer Research (p. 601-602) - 1/1/1985
- ISSN 02507005
- iMarina
USEFULNESS OF CA-15.3 SERIC LEVELS IN CLINICAL-PRACTICE
- RUIBAL, A
- COLOMER, R
- ROSELL, M
- GRIS, JM;
Tumour Biology (p. 315-315) - 1/1/1986
- ISSN 02895447
- iMarina
Prognosis factors in low grade non Hodgkin's lymphoma (NHL). Results of an analysis performed in 124 patients homogeneously treated.
- Arranz, R
- Llamas, P
- Blas, C
- Colomer, R
- Sobrino, P
- Nicolas, C
- Alfonso, PG
- Zamora, P
- Lopez, J
- Perez, G
- Garcialarana, J
- Lozano, M
- Fernandezranada, JM
Blood (p. 3868-3868) - 1/1/1997
- ISSN 00064971
- iMarina
A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature
- Gomez, H
- Colomer, R
- Casttellanos, D
- CortesFunes, H;
European Journal Of Cancer (p. 1205-1205) - 1/1/1997
- ISSN 09598049
- iMarina
Paclitaxel plus doxorubicin in metastatic breast cancer: Preliminary analysis of cardiotoxicity
- Miguel Martin
- Ana Lluch
- Belen Ojeda
- A Barnabas
- Ramon Colomer
- Bartomeu Massuti
- Dolores Benito
Seminars In Oncology (p. S17-26) - 8/12/1997
- ISSN 00937754
- iMarina
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer
- Hitt, R
- Hornedo, J
- Colomer, R
- Hidalgo, M
- Brandariz, A
- Pena, M
- Vicent, JA
- CortesFunes, H;
Seminars In Oncology (p. S2-58) - 22/3/1997
- ISSN 00937754
- iMarina
Circulating erbB-2 and resistance to chemotherapy in advanced breast cancer.
- R Colomer
- S Montero
- A Liuch
- B Ojeda
- A Barnadas
- A Casado
- B Massuti
- B Lloveras
- H Cortes-Funes
Clinical Cancer Research (p. 3772S-3772S) - 1/1/1999
- ISSN 15573265
- iMarina
Kinetic analysis of a combination of gemcitabine with vinorelbine in human breast adenocarcinoma MCF-7 cells in vitro
- Barbacid, MM
- Montero, S
- Menendez, JA
- Cortes-Funes, H
- Colomer, R;
European Journal Of Cancer (p. S14-S14) - 1/1/1999
- ISSN 09598049
- iMarina
Effect of oleic acid on the chemosensitivity of breast cancer cells
- Menendez, JA
- Barbacid, MM
- Montero, S
- Cortes-Funes, H
- Colomer, R;
European Journal Of Cancer (p. S14-S14) - 1/1/1999
- ISSN 09598049
- iMarina
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id